- Home
- AMRX vs COLD Comparison
AMRX vs COLD Comparison
Compare AMRX & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- COLD
- Stock Information
- Founded
- AMRX 2002
- COLD 1903
- Country
- AMRX United States
- COLD United States
- Employees
- AMRX N/A
- COLD N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- COLD Real Estate Investment Trusts
- Sector
- AMRX Health Care
- COLD Real Estate
- Exchange
- AMRX Nasdaq
- COLD Nasdaq
- Market Cap
- AMRX 3.3B
- COLD 3.2B
- IPO Year
- AMRX N/A
- COLD 2018
- Fundamental
- Price
- AMRX $11.62
- COLD $10.68
- Analyst Decision
- AMRX Buy
- COLD Hold
- Analyst Count
- AMRX 3
- COLD 15
- Target Price
- AMRX $12.67
- COLD $17.80
- AVG Volume (30 Days)
- AMRX 1.8M
- COLD 6.5M
- Earning Date
- AMRX 10-30-2025
- COLD 11-06-2025
- Dividend Yield
- AMRX N/A
- COLD 8.53%
- EPS Growth
- AMRX N/A
- COLD N/A
- EPS
- AMRX 0.02
- COLD N/A
- Revenue
- AMRX $2,934,959,000.00
- COLD $2,607,407,000.00
- Revenue This Year
- AMRX $10.20
- COLD N/A
- Revenue Next Year
- AMRX $6.95
- COLD $2.11
- P/E Ratio
- AMRX $620.20
- COLD N/A
- Revenue Growth
- AMRX 9.50
- COLD N/A
- 52 Week Low
- AMRX $6.69
- COLD $10.50
- 52 Week High
- AMRX $12.12
- COLD $24.22
- Technical
- Relative Strength Index (RSI)
- AMRX 63.04
- COLD 24.57
- Support Level
- AMRX $11.29
- COLD $12.35
- Resistance Level
- AMRX $12.12
- COLD $12.80
- Average True Range (ATR)
- AMRX 0.45
- COLD 0.51
- MACD
- AMRX 0.06
- COLD -0.22
- Stochastic Oscillator
- AMRX 77.70
- COLD 4.86
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About COLD Americold Realty Trust Inc.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.